Quest Laboratories Limited Share Price & Stock Analysis

Quest Laboratories Limited (NSE: QUESTLAB) is a Dhar, Madhya Pradesh-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹147 Cr, it ranks #2,906 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹92.90 (as of 16 Nov 2026), the share price is 39.1% below its 52-week high of ₹152.60 and 35.4% above its 52-week low of ₹68.60. The share price is up 5.8% over one year and up 0.6% over three months.

Key Metrics

Current Price₹92.90
Market Cap₹147 Cr
NSE SymbolQUESTLAB
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio10.2
Return on Equity16.82%
Return on Assets9.39%
52-Week Range₹68.60 – ₹152.60
1-Year Price Change+5.8%
3-Month Price Change+0.6%
Beta (1Y)0.58
HeadquartersDhar, Madhya Pradesh
Websitequestlabltd.com

Latest Quarterly Results — Q4 FY26

Revenue₹32 Cr
Net Profit₹3 Cr
Net Margin8.9%
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Quest Laboratories Limited Quarterly Revenue and Profit Trend

Quest Laboratories Limited reported revenue of ₹32 Cr in Q4 FY26, up 5.9% from ₹31 Cr in Q3 FY26. It posted a net profit of ₹3 Cr for the quarter, against a net profit of ₹4 Cr in Q3 FY26 (down 28.8%). Across the 4 quarters from Q1 FY26 to Q4 FY26, quarterly revenue ranged from ₹23 Cr (Q1 FY26) to ₹32 Cr (Q4 FY26). The company was profitable in each of these 4 quarters.

QuarterRevenueNet ProfitNet Margin
Q4 FY26₹32 Cr₹3 Cr8.9%
Q3 FY26₹31 Cr₹4 Cr13.2%
Q2 FY26₹26 Cr₹4 Cr15.7%
Q1 FY26₹23 Cr₹4 Cr17.7%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 66.78% of Quest Laboratories Limited's shares as of Mar 2026, against 66.21% in Mar 2025 (+0.57 percentage points).

About Quest Laboratories Limited

Quest Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. The company also engages in contract manufacturing activities for pharmaceutical companies. Quest Laboratories Limited was founded in 1994 and is based in Dhar, India.

Products and Services

1. Drugs And Chemicals-This segment engages in the manufacturing of pharmaceutical formulations across a spectrum, including antibiotics, antimalarial, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It produces various products, which include ethical drugs, generic drugs, and over-the-counter drugs in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, and external liquids. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Drugs And Chemicals-100%

Quest Laboratories Limited vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Quest Laboratories Limited₹147 Cr10.216.82%₹32 Cr+5.8%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Quest Laboratories Limited?

Quest Laboratories Limited is trading at ₹92.90, with a market capitalisation of ₹147 Cr.

Which sector does Quest Laboratories Limited belong to?

Quest Laboratories Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Quest Laboratories Limited?

Quest Laboratories Limited has a P/E of 10.2 and a return on equity of 16.82%.

What is the stock symbol of Quest Laboratories Limited?

Quest Laboratories Limited is listed on the NSE under the symbol QUESTLAB.

How has Quest Laboratories Limited's share price moved over the past year?

Quest Laboratories Limited's share price is up 5.8% over one year and up 0.6% over three months. Its 52-week range is ₹68.60 to ₹152.60.

What were Quest Laboratories Limited's latest quarterly results?

In Q4 FY26, Quest Laboratories Limited reported revenue of ₹32 Cr and net profit of ₹3 Cr (standalone, parsed from the company's exchange filing).

What is the promoter holding in Quest Laboratories Limited?

Promoters held 66.78% of Quest Laboratories Limited's shares as of Mar 2026, against 66.21% in Mar 2025 (+0.57 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.